Why is the A2 Milk share price sinking 9% today?

Investors have been hitting the sell button in a panic on Monday…

| More on:
Close up of a sad young woman reading about declining share price on her phone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • A2 Milk's shares are sinking following the release of its half year results
  • The infant formula company delivered strong growth thanks largely to its China business
  • Investors may have been betting on an even stronger result

The A2 Milk Company Ltd (ASX: A2M) share price is having a difficult time on Monday.

In morning trade, the infant formula company's shares are down 9% to $6.48.

Why is the A2 Milk share price sinking?

Investors have been hitting the sell button on Monday following the release of A2 Milk's half year results.

For the six months ended 31 December, the company reported an 18.6% increase in revenue to NZ$783.3 million and a 10.5% lift in EBITDA to NZ$107.8 million.

A key driver of A2 Milk's sales growth was its China label infant formula business, which delivered a 43.5% increase in sales. This helped offset largely flat English label sales and drove total infant formula sales growth of 18%.

On the bottom line, the company reported a 22% increase in net profit after tax to NZ$68.5 million. This was boosted by interest income of NZ$12.1 million, which appears to reflect A2 Milk's massive cash balance of approximately NZ$700 million and the benefits of rising interest rates.

Excluding this and finance costs, A2 Milk's earnings were up 10.5% year over year.

So, why are its shares under pressure?

Given that the A2 Milk share price was up strongly last week, it's possible that a lot of today's result (and perhaps even more) was already priced.

Furthermore, some investors may have been looking for a guidance upgrade today. However, management has provided guidance that is somewhat mixed compared to previous expectations.

It is now forecasting low double digit revenue growth in FY 2023, supported by growth in China label infant formula, ANZ liquid milk, and USA liquid milk sales. This is better than its previous guidance of "high single digit revenue growth in FY23."

However, it also now expects an EBITDA margin similar to FY 2022 levels of 13.6%. Whereas previously it was guiding to "a modest improvement in EBITDA margin."

Another potential disappointment is that its US infant formula sales are expected to be "immaterial" in FY 2023. It is possible that some investors were betting on its second half sales receiving a material boost from its US expansion.

Nevertheless, with the A2 Milk share price up 35% over the last six months, longer term shareholders won't be too disheartened by today's decline.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

Delighted adult man, working on a company slogan, on his laptop.
Earnings Results

Bank of Queensland share price leaps 6% on improving outlook

ASX 200 investors are bidding up the Bank of Queensland share price on Wednesday.

Read more »

Photo of two women shopping.
Earnings Results

Premier Investments share price jumps 9% on results and demerger plans

The Smiggle and Peter Alexander owner has released its results. How did it perform?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Earnings Results

Soul Patts share price struggles on falling profits

ASX 200 investment house Soul Patts reported its half year results this morning.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Earnings Results

Brickworks share price tumbles on disappointing half-year loss

This loss didn't stop the company from increasing its dividend again.

Read more »

A man sits on a bench atop a mountain with a laptop, making investments with a green ESG mind.
Earnings Results

ASX All Ords stock KMD tumbles as interim dividend cancelled

Investors are hitting the sell button on ASX All Ords stock KMD today.

Read more »

Coal miner holding a giant coal rock in his hand making a circle with his hand, symbolising a rising share price.
Energy Shares

New Hope share price charges higher despite profit crunch and huge dividend cut

Weaker coal prices have hit this miner's profits and dividend hard.

Read more »

A Chinese investor sits in front of his laptop looking pensive and concerned about pandemic lockdowns which may impact ASX 200 iron ore share prices
Earnings Results

Liontown share price tumbles 7% on half-year results

This lithium developer's results have been released this afternoon.

Read more »